Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-25

Clinical Trial Update: Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops

View source ↗

Summary

Completed clinical trial comparing tolerability of bimatoprost 0.01% eye drops versus latanoprost eye drops in glaucoma; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lumigan (bimatoprost)
  • Xalatan (latanoprost)

Snippet

Sponsor: MDbackline, LLC | Conditions: Glaucoma | Status: COMPLETED | Results posted: 2014-09-25